Phase 1 study of NOSO-502
Latest Information Update: 16 Feb 2023
At a glance
- Drugs NOSO 502 (Primary)
- Indications Gram-negative infections
- Focus Adverse reactions; First in man
Most Recent Events
- 16 Feb 2023 New trial record
Latest Information Update: 16 Feb 2023